Moxiclav (Amoxicillin, Clavulanic Acid)

Amoxicillin, the active ingredient in Moxiclav, is a beta‑lactam antibiotic presented as an injectable formulation for intravenous use. Combined with clavulanic acid, a beta‑lactamase inhibitor, the product expands coverage against beta‑lactamase‑producing bacteria and is used to treat serious infections such as respiratory, urinary, skin and soft‑tissue, and intra‑abdominal infections in both adult and pediatric patients.

GNH USA supplies Moxiclav as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory‑approved batches to meet the needs of healthcare institutions across multiple regions.

Moxiclav is indicated for bacterial infections affecting several organ systems, where it provides broad‑spectrum coverage.

- Respiratory tract infections: effective against community‑acquired pneumonia and bronchitis. - Urinary tract infections: treats complicated and uncomplicated infections caused by susceptible organisms. - Skin and soft‑tissue infections: resolves cellulitis, abscesses, and wound infections. - Intra‑abdominal infections: used for peritonitis and intra‑abdominal sepsis caused by mixed flora.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects: - Diarrhea: mild to moderate loose stools. - Nausea: occasional upset stomach. - Vomiting: transient episodes. - Rash: mild skin erythema. - Headache: transient cephalgia. - Elevated liver enzymes: transient transaminase rise.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder. - Clostridioides difficile colitis: severe intestinal inflammation. - Hepatotoxicity: significant liver injury. - Neutropenia: marked reduction in neutrophil count.

Use of Moxiclav requires careful assessment of patient factors and proper handling.

- Renal impairment: dose adjustment may be necessary. - Hepatic impairment: monitor liver function tests. - Allergy history: avoid in patients with known β‑lactam allergy. - Pregnancy and lactation: prescribe only if benefit outweighs potential risk. - Concomitant antibiotics: assess for possible antagonism. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moxiclav can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Allopurinol: increased risk of severe skin reactions. - Methotrexate: heightened toxicity and bone‑marrow suppression. - Warfarin: enhanced anticoagulant effect, monitor INR closely.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced hormonal efficacy, consider backup method. - Probenecid: decreased renal excretion, may raise plasma levels. - Aminoglycosides: potential antagonistic effect on bacterial killing.